{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:17:10Z","timestamp":1791494230923,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:00:00Z","timestamp":1619049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002767","name":"Hunan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2018SK52612"],"award-info":[{"award-number":["2018SK52612"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011496","name":"Changsha Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2017ZX09304014"],"award-info":[{"award-number":["2017ZX09304014"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019054","name":"Changsha Science and Technology Project","doi-asserted-by":"publisher","award":["kq1907151"],"award-info":[{"award-number":["kq1907151"]}],"id":[{"id":"10.13039\/501100019054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503073"],"award-info":[{"award-number":["81503073"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.biopha.2021.111652","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T02:28:56Z","timestamp":1623119336000},"page":"111652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Inhibition of Nrf2-mediated glucose metabolism by brusatol synergistically sensitizes acute myeloid leukemia to Ara-C"],"prefix":"10.1016","volume":"142","author":[{"given":"Cong","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xie-Lan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2021.111652_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2021.111652_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic glycolysis: meeting the metabolic requirements of cell proliferation","volume":"27","author":"Lunt","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"5930","key":"10.1016\/j.biopha.2021.111652_bib3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"9865","key":"10.1016\/j.biopha.2021.111652_bib4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0140-6736(12)61727-9","article-title":"Acute myeloid leukaemia in adults","volume":"381","author":"Ferrara","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2021.111652_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12967-019-1848-9","article-title":"Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients","volume":"17","author":"Wang","year":"2019","journal-title":"J. Transl.\u00a0Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.111652_bib6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12967-018-1463-1","article-title":"Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML)","volume":"16","author":"Zhu","year":"2018","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.biopha.2021.111652_bib7","doi-asserted-by":"crossref","first-page":"20322","DOI":"10.1002\/jcp.28632","article-title":"High expression of SLC38A1 predicts poor prognosis in patients with de novo acute myeloid leukemia","volume":"234","author":"Li","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111652_bib8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12967-019-1959-3","article-title":"Influence of DNMT3A R882 mutations on AML prognosis determined by the allele ratio in Chinese patients","volume":"17","author":"Yuan","year":"2019","journal-title":"J. Transl.\u00a0Med."},{"issue":"4","key":"10.1016\/j.biopha.2021.111652_bib9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ccell.2018.08.016","article-title":"Subversion of systemic glucose metabolism as a mechanism to support the growth of leukemia cells","volume":"34","author":"Ye","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.biopha.2021.111652_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1189\/jlb.0710417","article-title":"The level of glycolytic metabolism in acute myeloid leukemia blasts at diagnosis is prognostic for clinical outcome","volume":"89","author":"Herst","year":"2011","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111652_bib11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J. Gen. Physiol."},{"issue":"10","key":"10.1016\/j.biopha.2021.111652_bib12","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1182\/blood-2014-02-554204","article-title":"A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value","volume":"124","author":"Chen","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.biopha.2021.111652_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bcp.2012.11.016","article-title":"The Nrf2 cell defence pathway: keap1-dependent and -independent mechanisms of regulation","volume":"85","author":"Bryan","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"20","key":"10.1016\/j.biopha.2021.111652_bib14","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1128\/MCB.00915-07","article-title":"NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis","volume":"27","author":"Shin","year":"2007","journal-title":"Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111652_bib15","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/carcin\/bgp100","article-title":"Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice","volume":"30","author":"Yates","year":"2009","journal-title":"Carcinogenesis"},{"issue":"20","key":"10.1016\/j.biopha.2021.111652_bib16","doi-asserted-by":"crossref","first-page":"10228","DOI":"10.1093\/nar\/gks827","article-title":"Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks","volume":"40","author":"Hirotsu","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2021.111652_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101210","article-title":"Impairment of HIF-1\u03b1-mediated metabolic adaption by NRF2-silencing in breast cancer cells","volume":"24","author":"Lee","year":"2019","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111652_bib18","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1158\/0008-5472.CAN-10-3007","article-title":"NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1alpha","volume":"71","author":"Kim","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2021.111652_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biocel.2017.12.016","article-title":"NRF2 facilitates breast cancer cell growth via HIF1a-mediated metabolic reprogramming","volume":"95","author":"Zhang","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"11","key":"10.1016\/j.biopha.2021.111652_bib20","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1128\/MCB.01095-15","article-title":"Nrf2-mediated regulation of skeletal muscle glycogen metabolism","volume":"36","author":"Uruno","year":"2016","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2021.111652_bib21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.intimp.2019.03.023","article-title":"Nrf2 exerts mixed inflammation and glucose metabolism regulatory effects on murine RAW264.7 macrophages","volume":"71","author":"Ding","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111652_bib22","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.bbrc.2015.03.124","article-title":"Brusatol inhibits the response of cultured beta-cells to pro-inflammatory cytokines in vitro","volume":"460","author":"Turpaev","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.biopha.2021.111652_bib23","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1038\/sj.leu.2402696","article-title":"Brusatol-mediated induction of leukemic cell differentiation and G(1) arrest is associated with down-regulation of c-myc","volume":"16","author":"Mata-Greenwood","year":"2002","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.biopha.2021.111652_bib24","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1073\/pnas.1014275108","article-title":"Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism","volume":"108","author":"Ren","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2021.111652_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13578-019-0309-8","article-title":"Brusatol, an NRF2 inhibitor for future cancer therapeutic","volume":"9","author":"Cai","year":"2019","journal-title":"Cell Biosci."},{"issue":"12","key":"10.1016\/j.biopha.2021.111652_bib26","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/ptr.3477","article-title":"Seven quassinoids from Fructus Bruceae with cytotoxic effects on pancreatic adenocarcinoma cell lines","volume":"25","author":"Zhao","year":"2011","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2021.111652_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2360427","article-title":"Brusatol enhances the chemotherapy efficacy of gemcitabine in pancreatic cancer via the Nrf2 signalling pathway","volume":"2018","author":"Xiang","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"7","key":"10.1016\/j.biopha.2021.111652_bib28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/jps.2600680726","article-title":"Antitumor agents. XXXIV: mechanism of action of bruceoside A and Brusatol on nucleic acid metabolism of P-388 lymphocytic leukemia cells","volume":"68","author":"Hall","year":"1979","journal-title":"J. Pharm. Sci."},{"issue":"49","key":"10.1016\/j.biopha.2021.111652_bib29","doi-asserted-by":"crossref","first-page":"84974","DOI":"10.18632\/oncotarget.17761","article-title":"Exploring Brusatol as a new anti-pancreatic cancer adjuvant: biological evaluation and mechanistic studies","volume":"8","author":"Lu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2021.111652_bib30","doi-asserted-by":"crossref","first-page":"39123","DOI":"10.1038\/srep39123","article-title":"Brusatol inhibits HIF-1 signaling pathway and suppresses glucose uptake under hypoxic conditions in HCT116 cells","volume":"6","author":"Lu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.111652_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"issue":"3","key":"10.1016\/j.biopha.2021.111652_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0145-2126(97)00174-4","article-title":"Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents","volume":"22","author":"Banker","year":"1998","journal-title":"Leuk. Res."},{"issue":"6","key":"10.1016\/j.biopha.2021.111652_bib33","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/carcin\/bgn095","article-title":"Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2","volume":"29","author":"Wang","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2021.111652_bib34","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/oncsis.2015.50","article-title":"Hypoxia and metabolic adaptation of cancer cells","volume":"5","author":"Eales","year":"2016","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.biopha.2021.111652_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010234","article-title":"2-deoxy-d-glucose and its analogs: from diagnostic\u00a0to therapeutic agents","volume":"21","author":"Pajak","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.111652_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9304091","article-title":"Nrf2-mediated metabolic reprogramming in cancer","volume":"2018","author":"Wang","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.biopha.2021.111652_bib37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2174\/18715206113136660337","article-title":"Glucose-6-phosphate dehydrogenase: a biomarker and potential therapeutic target for cancer","volume":"14","author":"Zhang","year":"2014","journal-title":"Anticancer Agents Med. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2021.111652_bib38","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1111\/jcmm.14241","article-title":"Nrf2 promotes breast cancer cell migration via up-regulation of G6PD\/HIF-1alpha\/Notch1 axis","volume":"23","author":"Zhang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"116","key":"10.1016\/j.biopha.2021.111652_bib39","first-page":"251","article-title":"RRx-001, a novel clinical-stage chemosensitizer, radiosensitizer, and immunosensitizer, inhibits glucose 6-phosphate dehydrogenase in human tumor cells","volume":"21","author":"Oronsky","year":"2016","journal-title":"Disco Med."},{"key":"10.1016\/j.biopha.2021.111652_bib40","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2147\/OTT.S191621","article-title":"Mechanisms of drug resistance in acute myeloid leukemia","volume":"12","author":"Zhang","year":"2019","journal-title":"Oncol. Targets Ther."},{"issue":"5","key":"10.1016\/j.biopha.2021.111652_bib41","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/s41375-018-0070-8","article-title":"Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes","volume":"32","author":"Daver","year":"2018","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.biopha.2021.111652_bib42","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.drudis.2018.05.040","article-title":"Advances in treatment formulations for acute myeloid leukemia","volume":"23","author":"Briot","year":"2018","journal-title":"Drug Disco Today"},{"issue":"5","key":"10.1016\/j.biopha.2021.111652_bib43","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1021\/acschembio.7b01025","article-title":"A complementary chemical and genomic screening approach for druggable targets in the nrf2 pathway and small molecule inhibitors to overcome cancer cell drug resistance","volume":"13","author":"Matthews","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.biopha.2021.111652_bib44","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.biopha.2018.06.065","article-title":"Comprehensive anti-tumor effect of Brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K\/Akt\/mTOR pathway in hepatocellular carcinoma","volume":"105","author":"Ye","year":"2018","journal-title":"Biomed. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111652_bib45","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jep.2009.04.058","article-title":"Hypoglycemic effect of quassinoids from Brucea javanica (L.) Merr (Simaroubaceae) seeds","volume":"124","author":"NoorShahida","year":"2009","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2021.111652_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17070997","article-title":"Brusatol enhances the radiosensitivity of A549 cells by promoting ROS production and enhancing DNA damage","volume":"17","author":"Sun","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2021.111652_bib47","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the intersections between metabolism and cancer biology","volume":"168","author":"Vander Heiden","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2021.111652_bib48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.biopha.2021.111652_bib49","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrc.2016.77","article-title":"Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?","volume":"16","author":"Hay","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"13","key":"10.1016\/j.biopha.2021.111652_bib50","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/pros.21172","article-title":"Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies","volume":"70","author":"Stein","year":"2010","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.biopha.2021.111652_bib51","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20101470","article-title":"Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme","volume":"208","author":"Wolf","year":"2011","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.biopha.2021.111652_bib52","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1172\/JCI69741","article-title":"Targeting lactate metabolism for cancer therapeutics","volume":"123","author":"Doherty","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"43","key":"10.1016\/j.biopha.2021.111652_bib53","doi-asserted-by":"crossref","first-page":"E6669","DOI":"10.1073\/pnas.1603876113","article-title":"ATM\/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia","volume":"113","author":"Gregory","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.biopha.2021.111652_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080805","article-title":"Metabolic plasticity of acute myeloid leukemia","volume":"8","author":"Kreitz","year":"2019","journal-title":"Cells"},{"issue":"13","key":"10.1016\/j.biopha.2021.111652_bib55","doi-asserted-by":"crossref","first-page":"8348","DOI":"10.1074\/jbc.M114.618769","article-title":"Rewired metabolism in drug-resistant leukemia cells: a metabolic switch hallmarked by reduced dependence on exogenous glutamine","volume":"290","author":"St\u00e4ubert","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2021.111652_bib56","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Hayes","year":"2014","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111652_bib57","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2012.05.016","article-title":"Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming","volume":"22","author":"Mitsuishi","year":"2012","journal-title":"Cancer Cell"},{"issue":"22","key":"10.1016\/j.biopha.2021.111652_bib58","doi-asserted-by":"crossref","first-page":"32375","DOI":"10.18632\/oncotarget.8632","article-title":"Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis","volume":"7","author":"Kowalik","year":"2016","journal-title":"Oncotarget"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221004340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221004340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:30:25Z","timestamp":1760099425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221004340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":58,"alternative-id":["S0753332221004340"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111652","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Nrf2-mediated glucose metabolism by brusatol synergistically sensitizes acute myeloid leukemia to Ara-C","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111652"}}